BlackRock vs Morgan Stanley
BLK and MS side by side, both in security brokers, dealers, and flotation. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BLK and MS compare
BlackRock is the larger company, worth 1.3 times as much as Morgan Stanley ($373B against $289B).
On earnings, Morgan Stanley is cheaper: it trades at 14.9× trailing earnings, against 27.4× for BlackRock.
BlackRock grew revenue faster over the last twelve months (26.5% versus 18.0% for Morgan Stanley).
Morgan Stanley keeps more of each dollar of sales as profit, with a net margin of 25.8% compared with 24.1% at BlackRock.
Both pay dividends: BlackRock yields 2.0% and Morgan Stanley 2.3%.
Morgan Stanley scores higher on the StockData Score (17 against 12 for BlackRock), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BLK | MS |
|---|---|---|
| Size and price | ||
| Market cap | $373B | $289B |
| Share price | $1147.54 | $184.30 |
| Change, 1 year | 4.5% | 12.4% |
| Change, 5 years | 20.1% | 84.5% |
| Beta (5Y) | 1.34 | 1.20 |
| Employees | 25K | 83K |
| StockData Score | ||
| Total score | 12 | 17 (better) |
| Valuation score | 0 | 4 (better) |
| Growth score | 3 (better) | 2 |
| Performance score | 3 | 4 (better) |
| Health score | 4 | 4 |
| Dividend score | 2 | 3 (better) |
| Valuation | ||
| P/E | 27.4× | 14.9× (better) |
| P/S | 13.7× | 3.7× (better) |
| P/B | 6.5× | 2.5× (better) |
| EV/EBITDA | 35.0× | – |
| P/FCF | 106× | – |
| PEG | 21.13 | 0.81 (better) |
| FCF yield | 0.94% | – |
| Fair value | $644.14 | $190.74 |
| Margin of safety | −78.1% | 3.4% (better) |
| Growth | ||
| Revenue growth (TTM) | 26.5% (better) | 18.0% |
| Revenue growth, 5Y average | 8.4% (better) | 7.7% |
| Net income growth (TTM) | 2.7% | 36.6% (better) |
| EPS growth (TTM) | 1.2% | 40.1% (better) |
| EPS growth, 5Y average | 2.1% | 9.6% (better) |
| Profitability | ||
| Operating margin | 32.6% | – |
| Net margin | 24.1% | 25.8% (better) |
| FCF margin | 12.9% | – |
| Return on equity | 12.3% | 18.0% (better) |
| Return on invested capital | 15.9% | – |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Interest coverage | 16.4× | – |
| Altman Z-score | 2.33 (better) | 0.26 |
| Piotroski F-score | 4 | 5 (better) |
| Dividends and buybacks | ||
| Dividend yield | 2.0% | 2.3% (better) |
| Payout ratio | – | 33.6% |
| Years of dividend growth | 3 | 12 (better) |
| Dividend growth, 5Y average | – | 22.4% |
| Shareholder yield | 2.0% | 2.3% (better) |
| Ownership | ||
| Held by institutions | 37.0% | 85.9% |
| Held by insiders | 0.94% | 24.4% |
| Insider net buying, 12 months | −$192M | −$51.7M (better) |
| Superinvestors holding | 4 (better) | 2 |
| Short interest, % of float | 0.63% | 1.2% |
Go deeper
- BLK stock overview
- BLK income statement
- BLK valuation and score
- MS stock overview
- MS income statement
- MS valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.